Please use this identifier to cite or link to this item: http://scholarbank.nus.edu.sg/handle/10635/18879
Title: Development of hybrid promoters and viral vectors for improved gene delivery to the central nervous system
Authors: WANG CHAOYANG
Keywords: gene therapy; central nervous system; Parkinson’s disease; hybrid promoter; adeno-associated virus; baculovirus.
Issue Date: 25-Jan-2006
Source: WANG CHAOYANG (2006-01-25). Development of hybrid promoters and viral vectors for improved gene delivery to the central nervous system. ScholarBank@NUS Repository.
Abstract: The purpose of this study was to develop suitable delivery systems with novel promoters and viral vectors for gene therapy of disorders in the CNS, particularly Parkinsona??s disease and malignant glioma tumors. By adding the enhancer of cytomegalovirus immediate-early gene to the upstream of cellular promoters, hybrid CMV E/PDGF promoter and CMV E/GFAP promoter were constructed. Improved transcriptional activities and retained cell type specificities were observed by in vitro and in vivo gene delivery with viral vectors. The results showed that a neuron-specific, high level, and long-term transgene expression can be achieved with AAV-2 vector carrying the CMV E/PDGF promoter, while a high level, transient and neuron- or astrocyte-specific transgene can be observed with baculovirus vectors carrying the CMV E/PDGF promoter or CMV E/GFAP promoter. ITR-flanking improved the baculovirus-mediated transgene expression further. In conclusion, with hybrid promoters and viral vectors, this study provides useful delivery systems for gene therapy of disorders in the CNS.
URI: http://scholarbank.nus.edu.sg/handle/10635/18879
Appears in Collections:Ph.D Theses (Open)

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
WangCY.pdf3.36 MBAdobe PDF

OPEN

NoneView/Download

Page view(s)

231
checked on Dec 8, 2017

Download(s)

297
checked on Dec 8, 2017

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.